Specific imaging of bacterial infection using 6''-18F-fluoromaltotriose: A second-generation PET tracer targeting the maltodextrin transporter in bacteria

Journal of Nuclear Medicine

Volumn 58, Issue 10, 2017, Pages 1679-1684

  Gowrishankar, Gayatri ^a   Hardy, Jonathan ^a   Wardak, Mirwais ^a   Namavari, Mohammad ^a   Reeves, Robert E ^b   Neofytou, Evgenios ^a   Srinivasan, Ananth ^a   Wu, Joseph C ^a   Contag, Christopher H ^a   Gambhir, Sanjiv Sam ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Thermo Fisher Scientific   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

6'' 18F fluoromaltotriose; Bacteria; Infection imaging; PET CT imaging

Indexed keywords

6'' FLUOROMALTOTRIOSE F 18; CARRIER PROTEIN; MALTODEXTRIN TRANSPORTER; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 6''-FLUOROMALTOTRIOSE; MALTODEXTRIN; MALTOTRIOSE; POLYSACCHARIDE; TRACER; TRISACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM DETECTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MOUSE; MYOSITIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS INFECTION; WOUND INFECTION; ANIMAL; DIAGNOSTIC IMAGING; METABOLISM; NUDE MOUSE; PROCEDURES; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BACTERIAL INFECTIONS; BIOLOGICAL TRANSPORT; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, NUDE; POLYSACCHARIDES; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; TRISACCHARIDES; WOUND INFECTION;

EID: 85030858244     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.117.191452     Document Type: Article

References (30)

1. Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS. Antimicrobial resistance. JAMA. 2016;316:1193-1204.
2. Morens DM, Fauci AS. Emerging infectious diseases: threats to human health and global stability. PLoS Pathog. 2013;9:e1003467.
3. Antibiotic resistant threats in the United States. Centers for Disease Control and Prevention website. https://www.cdc.gov/drugresistance/threat-report-2013/. Updated April 10, 2017. Accessed August 25, 2017.
4. National action plan for combating antibiotic resistant bacteria. Centers for Disease Control and Prevention website. https://www.cdc.gov/drugresistance/pdf/national-action-plan-for-combating-antibotic-resistant-bacteria.pdf. March 2015. Accessed August 25, 2017.
5. Janda JM, Abbott SL. 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: pluses, perils, and pitfalls. J Clin Microbiol. 2007;45: 2761-2764.
6. Sasser TA, Van Avermaete AE, White A, et al. Bacterial infection probes and imaging strategies in clinical nuclear medicine and preclinical molecular imaging. Curr Top Med Chem. 2013;13:479-487.
7. van Oosten M, Hahn M, Crane LM, et al. Targeted imaging of bacterial infections: advances, hurdles and hopes. FEMS Microbiol Rev. 2015;39:892-916.
8. Bunschoten A, Welling MM, Termaat MF, Sathekge M, van Leeuwen FW. Development and prospects of dedicated tracers for the molecular imaging of bacterial infections. Bioconjug Chem. 2013;24:1971-1989.
9. Peterson KL, Reid WC, Freeman AF, et al. The use of 14C-FIAU to predict bacterial thymidine kinase presence: implications for radiolabeled FIAU bacterial imaging. Nucl Med Biol. 2013;40:638-642.
10. Diaz LA Jr, Foss CA, Thornton K, et al. Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT. PLoS One. 2007;2:e1007.
11. Ebenhan T, Zeevaart JR, Venter JD, et al. Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging. J Nucl Med. 2014;55:308-314.
12. Vilche M, Reyes AL, Vasilskis E, Oliver P, Balter H, Engler H. 68Ga-NOTAUBI-29-41 as a PET tracer for detection of bacterial infection. J Nucl Med. 2016;57:622-627.
13. Weinstein EA, Ordonez AA, DeMarco VP, et al. Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography. Sci Transl Med. 2014;6:259ra146.
14. Gowrishankar G, Namavari M, Jouannot EB, et al. Investigation of 6-[18F]-fluoromaltose as a novel PET tracer for imaging bacterial infection. PLoS One. 2014;9:e107951.
15. Namavari M, Gowrishankar G, Hoehne A, Jouannot E, Gambhir SS. Synthesis of [18F]-labelled maltose derivatives as PET tracers for imaging bacterial infection. Mol Imaging Biol. 2015;17:168-176.
16. Ning X, Lee S, Wang Z, et al. Maltodextrin-based imaging probes detect bacteria in vivo with high sensitivity and specificity. Nat Mater. 2011;10:602-607.
17. Ferenci T. The recognition of maltodextrins by Escherichia coli. Eur J Biochem. 1980;108:631-636.
18. Gopal S, Berg D, Hagen N, et al. Maltose and maltodextrin utilization by Listeria monocytogenes depend on an inducible ABC transporter which is repressed by glucose. PLoS One. 2010;5:e10349.
19. Hanses F, Roux C, Dunman PM, Salzberger B, Lee JC. Staphylococcus aureus gene expression in a rat model of infective endocarditis. Genome Med. 2014;6:93-109.
20. Jones SA, Jorgensen M, Chowdhury FZ, et al. Glycogen and maltose utilization by Escherichia coli O157:H7 in the mouse intestine. Infect Immun. 2008;76: 2531-2540.
21. Lang H, Jonson G, Holmgren J, Palva ET. The maltose regulon of Vibrio cholerae affects production and secretion of virulence factors. Infect Immun. 1994;62:4781-4788.
22. Ferenci T. Methyl-alpha-maltoside and 5-thiomaltose: analogs transported by the Escherichia coli maltose transport system. J Bacteriol. 1980;144:7-11.
23. Ning X, Seo W, Lee S, et al. PET imaging of bacterial infections with fluorine-18-labeled maltohexaose. Angew Chem Int Ed Engl. 2014;53:14096-14101.
24. Shelburne SA, 3rd, Sumby P, Sitkiewicz I, et al. Maltodextrin utilization plays a key role in the ability of group A Streptococcus to colonize the oropharynx. Infect Immun. 2006;74:4605-4614.
25. Zastrow CR, Hollatz C, de Araujo PS, Stambuk BU. Maltotriose fermentation by Saccharomyces cerevisiae. J Ind Microbiol Biotechnol. 2001;27:34-38.
26. Garrido V, Collantes M, Barberan M, et al. In vivo monitoring of Staphylococcus aureus biofilm infections and antimicrobial therapy by [18F]fluoro-deoxyglucose-MicroPET in a mouse model. Antimicrob Agents Chemother. 2014;58:6660-6667.
27. Bjarnsholt T, Alhede M, Alhede M, et al. The in vivo biofilm. Trends Microbiol. 2013;21:466-474.
28. Tr?strup H, Thomsen K, Christophersen LJ, et al. Pseudomonas aeruginosa biofilm aggravates skin inflammatory response in BALB/c mice in a novel chronic wound model. Wound Repair Regen. 2013;21:292-299.
29. Merrick JC, Edelson BT, Bhardwaj V, Swanson PE, Unanue ER. Lymphocyte apoptosis during early phase of Listeria infection in mice. Am J Pathol. 1997;151: 785-792.
30. Ordonez AA, Weinstein EA, Bambarger LE, et al. A systematic approach for developing bacteria-specific imaging tracers. J Nucl Med. 2017;58:144-150.